These findings highlight a clear pattern: Ozempic can cause not only fat loss, but also a meaningful reduction in lean muscle tissuesometimes up to one-third or more of the total weight lost
Management options may include lifestyle modifications, treatment of underlying cardiovascular disease, psychological support, or specific ED therapies such as phosphodiesterase-5 inhibitors (e.g., sildenafil), which can be safely used alongside tirzepatide in most patients following cardiovascular assessment
Before any lifting session, spend 5-10 minutes warming up
GLP-1 receptor agonists may be discussed when obesity and cardiometabolic risk are central issues, but treatment decisions depend on labeling, coverage, and clinical context
Some people just dont make enough of their own DAO enzyme